• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cogstate简明成套测验中个体及综合测试分数对轻度认知障碍和阿尔茨海默病所致痴呆的敏感性。

Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.

作者信息

White Joshua P, Schembri Adrian, Prenn-Gologranc Carmen, Ondrus Matej, Katina Stanislav, Novak Petr, Lim Yen Ying, Edgar Chris, Maruff Paul

机构信息

Cogstate Ltd, Melbourne, Victoria, Australia.

AXON Neuroscience CRM Services SE, Bratislava, Slovakia.

出版信息

J Alzheimers Dis. 2023;96(4):1781-1799. doi: 10.3233/JAD-230352.

DOI:10.3233/JAD-230352
PMID:38007647
Abstract

BACKGROUND

The Cogstate Brief Battery (CBB) is a computerized cognitive test battery used commonly to identify cognitive deficits related to Alzheimer's disease (AD). However, AD and normative samples used to understand the sensitivity of the CBB to AD in the clinic have been limited, as have the outcome measures studied.

OBJECTIVE

This study investigated the sensitivity of CBB outcomes, including potential composite scores, to cognitive impairment in mild cognitive impairment (MCI) and dementia due to AD, in carefully selected samples.

METHODS

Samples consisted of 4,871 cognitively unimpaired adults and 184 adults who met clinical criteria for MCI (Clinical Dementia Rating (CDR) = 0.5) or dementia (CDR > 0.5) due to AD and CBB naive. Speed and accuracy measures from each test were examined, and theoretically- and statistically-derived composites were created. Sensitivity and specificity of classification of cognitive impairment were compared between outcomes.

RESULTS

Individual CBB measures of learning and working memory showed high discriminability for AD-related cognitive impairment for CDR 0.5 (AUCs ∼ 0.79-0.88), and CDR > 0.5 (AUCs ∼ 0.89-0.96) groups. Discrimination ability for theoretically derived CBB composite measures was high, particularly for the Learning and Working Memory (LWM) composite (CDR 0.5 AUC = 0.90, CDR > 0.5 AUC = 0.97). As expected, statistically optimized linear composite measures showed strong discrimination abilities albeit similar to the LWM composite.

CONCLUSIONS

In older adults, the CBB is effective for discriminating cognitive impairment due to MCI or AD-dementia from unimpaired cognition with the LWM composite providing the strongest sensitivity.

摘要

背景

Cogstate简易成套测验(CBB)是一种计算机化认知测验组合,常用于识别与阿尔茨海默病(AD)相关的认知缺陷。然而,在临床上用于了解CBB对AD敏感性的AD样本和正常样本有限,所研究的结果指标也是如此。

目的

本研究在精心挑选的样本中,调查CBB结果(包括潜在的综合得分)对轻度认知障碍(MCI)和AD所致痴呆中认知障碍的敏感性。

方法

样本包括4871名认知未受损的成年人以及184名符合MCI临床标准(临床痴呆评定量表(CDR)=0.5)或AD所致痴呆(CDR>0.5)且未使用过CBB的成年人。检查了每项测验的速度和准确性指标,并创建了理论上和统计得出的综合指标。比较了各结果之间认知障碍分类的敏感性和特异性。

结果

CBB中学习和工作记忆的个体测量指标对CDR 0.5(曲线下面积[AUCs]约为0.79 - 0.88)和CDR>0.5(AUCs约为0.89 - 0.96)组的AD相关认知障碍显示出高辨别力。理论上得出的CBB综合测量指标的辨别能力很高,尤其是学习和工作记忆(LWM)综合指标(CDR 0.5时AUC = 0.90,CDR>0.5时AUC = 0.97)。正如预期的那样,统计优化的线性综合指标显示出很强的辨别能力,尽管与LWM综合指标相似。

结论

在老年人中,CBB能有效区分MCI或AD痴呆所致的认知障碍与未受损认知,其中LWM综合指标的敏感性最强。

相似文献

1
Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease.Cogstate简明成套测验中个体及综合测试分数对轻度认知障碍和阿尔茨海默病所致痴呆的敏感性。
J Alzheimers Dis. 2023;96(4):1781-1799. doi: 10.3233/JAD-230352.
2
Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.简易认知状态成套测验和听觉词语学习测验在临床前阿尔茨海默病和新发轻度认知障碍中的诊断和预后准确性:对定义轻微客观认知障碍的影响。
J Alzheimers Dis. 2020;76(1):261-274. doi: 10.3233/JAD-200087.
3
Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease. cogstate 简短电池在识别轻度认知障碍和阿尔茨海默病认知障碍中的临床效用。
BMC Psychol. 2013 Dec 23;1(1):30. doi: 10.1186/2050-7283-1-30. eCollection 2013.
4
Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (MCI A T ) in a population-based sample.基于人群样本的 Cogstate 简明电池对普遍 MCI 和前驱 AD(MCI A T )的诊断准确性。
Alzheimers Dement. 2021 Apr;17(4):584-594. doi: 10.1002/alz.12219. Epub 2021 Mar 1.
5
Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries.计算机化认知测试在临床试验中的应用:NIH 工具包和 Cogstate C3 电池的比较。
J Prev Alzheimers Dis. 2017;4(1):3-11. doi: 10.14283/jpad.2017.1.
6
Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.简易CogState测试组表现、其他认知功能测量指标与阿尔茨海默病风险人群生物标志物之间的关联
J Alzheimers Dis. 2016 Oct 18;54(4):1395-1408. doi: 10.3233/JAD-160528.
7
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.在澳大利亚成像、生物标志物和生活方式(AIBL)研究中,使用 CogState 简明电池评估与阿尔茨海默病相关的认知障碍。
J Clin Exp Neuropsychol. 2012;34(4):345-58. doi: 10.1080/13803395.2011.643227. Epub 2012 Jan 17.
8
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).健康老年人、轻度认知障碍和阿尔茨海默病患者中 CogState 简明电池的 3 个月稳定性:来自澳大利亚成像、生物标志物和生活方式-变化率亚研究(AIBL-ROCS)的结果。
Arch Clin Neuropsychol. 2013 Jun;28(4):320-30. doi: 10.1093/arclin/act021. Epub 2013 Apr 3.
9
Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.帕金森病与阿尔茨海默病中的轻度认知障碍。
Parkinsonism Relat Disord. 2016 Jun;27:54-60. doi: 10.1016/j.parkreldis.2016.04.007. Epub 2016 Apr 9.
10
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.生物标志物组合对预测轻度认知障碍向阿尔茨海默病痴呆进展的增量价值。
Alzheimers Res Ther. 2017 Oct 10;9(1):84. doi: 10.1186/s13195-017-0301-7.

引用本文的文献

1
Machine Learning-Based Cognitive Assessment With The Autonomous Cognitive Examination: Randomized Controlled Trial.基于机器学习的自主认知检查认知评估:随机对照试验。
J Med Internet Res. 2025 Jul 30;27:e67446. doi: 10.2196/67446.
2
Cognitive Deficits in Late-Life Depression: From Symptoms and Assessment to Therapeutics.老年期抑郁症的认知缺陷:从症状、评估到治疗
Focus (Am Psychiatr Publ). 2025 Apr;23(2):183-194. doi: 10.1176/appi.focus.20240046. Epub 2025 Apr 15.
3
Rural Roads to cognitive Resilience (RRR): A prospective cohort study protocol.
农村道路与认知恢复力(RRR):一项前瞻性队列研究方案
PLoS One. 2025 Jan 13;20(1):e0312660. doi: 10.1371/journal.pone.0312660. eCollection 2025.
4
Rural Roads to Cognitive Resilience (RRR): A prospective cohort study protocol.通往认知恢复力的乡村道路(RRR):一项前瞻性队列研究方案。
medRxiv. 2024 Oct 14:2024.10.13.24315411. doi: 10.1101/2024.10.13.24315411.